Encompass Health Co. Forecasted to Earn Q3 2024 Earnings of $0.89 Per Share (NYSE:EHC)

Posted by Defense World Staff on Apr 6th, 2023

Encompass Health Co. (NYSE:EHC – Get Rating) – William Blair cut their Q3 2024 earnings estimates for shares of Encompass Health in a report released on Monday, April 3rd. William Blair analyst M. Larew now expects that the company will earn $0.89 per share for the quarter, down from their prior estimate of $0.99. The consensus estimate for Encompass Health’s current full-year earnings is $3.07 per share. William Blair also issued estimates for Encompass Health’s Q4 2024 earnings at $0.99 EPS.

A number of other equities research analysts have also recently issued reports on EHC. Mizuho upped their price objective on shares of Encompass Health from $65.00 to $69.00 and gave the company a “buy” rating in a research note on Thursday, February 9th. Truist Financial upped their price target on shares of Encompass Health from $70.00 to $75.00 and gave the company a “buy” rating in a report on Thursday, February 9th. Credit Suisse Group upped their price target on shares of Encompass Health from $62.00 to $73.00 and gave the company an “outperform” rating in a report on Thursday, February 9th. UBS Group upped their price target on shares of Encompass Health from $68.00 to $73.00 in a report on Wednesday, February 8th. Finally, Barclays upped their price target on shares of Encompass Health from $57.00 to $61.00 and gave the company an “equal weight” rating in a report on Tuesday. Two research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $69.40.

Encompass Health Price Performance

Shares of Encompass Health stock opened at $61.07 on Wednesday. Encompass Health has a 52-week low of $44.33 and a 52-week high of $74.61. The stock has a market capitalization of $6.09 billion, a price-to-earnings ratio of 22.62, a price-to-earnings-growth ratio of 1.26 and a beta of 1.05. The company has a fifty day moving average of $57.45 and a 200-day moving average of $55.82. The company has a debt-to-equity ratio of 1.50, a quick ratio of 1.25 and a current ratio of 1.25.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, April 17th. Stockholders of record on Monday, April 3rd will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date of this dividend is Friday, March 31st. Encompass Health’s payout ratio is presently 22.22%.

Insider Activity

In other news, CFO Douglas E. Coltharp sold 17,895 shares of the firm’s stock in a transaction dated Friday, February 10th. The shares were sold at an average price of $60.78, for a total transaction of $1,087,658.10. Following the sale, the chief financial officer now owns 53,097 shares of the company’s stock, valued at approximately $3,227,235.66. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 2.70% of the company’s stock.

Hedge Funds Weigh In On Encompass Health

Several institutional investors have recently made changes to their positions in the business. Lazard Asset Management LLC lifted its stake in shares of Encompass Health by 14.3% in the 4th quarter. Lazard Asset Management LLC now owns 1,290 shares of the company’s stock worth $77,000 after purchasing an additional 161 shares during the period. Bank of Montreal Can lifted its stake in shares of Encompass Health by 1.5% in the 1st quarter. Bank of Montreal Can now owns 11,340 shares of the company’s stock worth $806,000 after purchasing an additional 173 shares during the period. Commonwealth Equity Services LLC lifted its stake in shares of Encompass Health by 3.9% in the 4th quarter. Commonwealth Equity Services LLC now owns 4,692 shares of the company’s stock worth $280,000 after purchasing an additional 174 shares during the period. Horrell Capital Management Inc. raised its stake in Encompass Health by 0.6% during the 4th quarter. Horrell Capital Management Inc. now owns 29,330 shares of the company’s stock worth $1,754,000 after acquiring an additional 185 shares during the period. Finally, Louisiana State Employees Retirement System raised its stake in Encompass Health by 0.8% during the 4th quarter. Louisiana State Employees Retirement System now owns 26,700 shares of the company’s stock worth $1,597,000 after acquiring an additional 200 shares during the period. Institutional investors own 96.14% of the company’s stock.

About Encompass Health

(Get Rating)

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations.

Earnings History and Estimates for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.